Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review.

Michelle D HackshawHeather E DanyshMackenzie HendersonEric WangNora TuZahidul IslamAmy LadnerMary E RitcheyMaribel Salas

Published in: BMC cancer (2021)

More research is needed to better understand risk factors for BM and survival after BM in the context of HER2+ BC, as well as the assessment of new anti-HER2 therapy regimens that may provide additional therapeutic options for BM in these patients.

Keyphrases

prognostic factors
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
metastatic breast cancer
peritoneal dialysis
white matter
bone marrow
cell therapy